查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1538237

单采市场报告：2030 年趋势、预测与竞争分析

Apheresis Market Report: Trends, Forecast and Competitive Analysis to 2030
出版日期: | 出版商: Lucintel | 英文 150 Pages | 商品交期: 3个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

单采趋势和预测

预计到 2030 年，全球单采市场将达到 23 亿美元，2024 年至 2030 年复合年增长率为 7.5%。市场的主要驱动因素是慢性肾臟病盛行率的上升、政府鼓励捐血的宣传活动加大以及对血液成分的需求不断增长。全球单采市场的未来看起来充满希望，血液中心和医院市场充满机会。

按分段进行血浆分离术

本研究包括按产品类型、方法、程序、最终用途和地区分類的全球单采预测。

单采市场洞察

Lucintel 预计，由于离心在新鲜冰冻血浆和浓缩红血球等血液成分的製备中被广泛采用，因此在预测期内离心仍将是最大的细分市场。

在这个市场中，血液中心在预测期内可能仍占较大份额。

由于越来越多地采用最先进的单采系统以及该地区人口中血液相关疾病的盛行率不断增加，北美在预测期内仍将是最大的地区。

常问问题

Q1.市场规模为：

A1. 到 2030 年，全球单采血液市场预计将达到 23 亿美元。

Q2.市场成长预测是多少：

A2. 2024年至2030年，全球单采市场预计将以7.5%的复合年增长率成长。

Q3.影响市场成长的主要驱动因素是：

A3. 这个市场的主要驱动因素是慢性肾臟病盛行率的上升、政府鼓励捐血的宣传活动不断增加以及对血液成分的需求不断增长。

Q4.市场的主要细分市场是：

A4. 单采市场前景广阔，血液中心和医院市场充满机会。

Q5.市场的主要企业是：

A5. 主要的单采公司如下：

  • Kawasumi Laboratories
  • Nikkiso
  • Haemonetics Corporation
  • Asahi Kasei Medical
  • Cerus Corporation
  • Kaneka Corporation
  • Charles River Laboratories International
  • B. Braun Melsungen
  • Fresenius Kabi
  • Terumo BCT

Q6.未来最大的细分市场是什么？

A6.Lucintel 预测，由于离心在血液成分（包括新鲜冰冻血浆和浓缩红血球）的製备中广泛采用，因此在预测期内离心仍将是最大的部分。

Q7. 未来五年预计哪些地区的市场成长最大？

A7. 由于最先进的单采系统的日益普及以及该地区人口中血液相关疾病的患病率不断增加，北美在预测期内仍将是最大的地区。

Q8. 可以客製化报告吗？

A8. 是的，Lucintel 提供 10% 的客製化服务，无需额外付费。

目录

第一章执行摘要

第二章全球单采市场：市场动态

  • 简介、背景、分类
  • 供应链
  • 产业驱动因素与挑战

第三章 2018-2030年市场趋势及预测分析

  • 宏观经济趋势（2018-2023）与预测（2024-2030）
  • 全球单采市场趋势（2018-2023）与预测（2024-2030）
  • 按产品类型分類的全球单采市场
    • 一次性用品和试剂
    • 软体
    • 装置
  • 按方法分類的全球单采市场
    • 离心
    • 膜分离
    • 选择性吸附
  • 按程序分類的全球单采市场
    • 供体/自动血浆分离术
    • 治疗血浆分离术
  • 以最终用途分類的全球单采市场
    • 血液中心
    • 医院
    • 其他的

第四章 2018-2030年区域市场趋势及预测分析

  • 按地区分類的全球单采市场
  • 北美单采市场
  • 欧洲单采市场
  • 亚太地区单采市场
  • 其他地区单采市场

第五章 竞争分析

  • 产品系列分析
  • 业务整合
  • 波特五力分析

第六章 成长机会与策略分析

  • 成长机会分析
    • 按产品类型分類的全球单采市场成长机会
    • 按方法分類的全球单采市场成长机会
    • 按程序分類的全球单采市场成长机会
    • 按最终用途分類的全球单采市场成长机会
    • 按地区分類的全球单采市场成长机会
  • 全球单采市场新趋势
  • 战略分析
    • 新产品开发
    • 扩大全球单采市场的产能
    • 全球单采市场的合併、收购及合资企业
    • 认证和许可

第七章主要企业概况

  • Kawasumi Laboratories
  • Nikkiso
  • Haemonetics Corporation
  • Asahi Kasei Medical
  • Cerus Corporation
  • Kaneka Corporation
  • Charles River Laboratories International
  • B. Braun Melsungen
  • Fresenius Kabi
  • Terumo BCT
简介目录

Apheresis Trends and Forecast

The future of the global apheresis market looks promising with opportunities in the blood center and hospital markets. The global apheresis market is expected to reach an estimated $2.3 billion by 2030 with a CAGR of 7.5% from 2024 to 2030. The major drivers for this market are rising prevalence of chronic renal diseases, increasing government campaigns encouraging blood donation, and expanding demand for blood components.

A more than 150-page report is developed to help in your business decisions. Sample figures with some insights are shown below.

Apheresis by Segment

The study includes a forecast for the global apheresis by product type, method, procedure, end use, and region.

Apheresis Market by Product Type [Shipment Analysis by Value from 2018 to 2030]:

  • Disposable and Reagents
  • Software
  • Devices

Apheresis Market by Method [Shipment Analysis by Value from 2018 to 2030]:

  • Centrifugation
  • Membrane Separation
  • Selective Adsorption

Apheresis Market by Procedure [Shipment Analysis by Value from 2018 to 2030]:

  • Donor/Automated Apheresis
  • Therapeutic Apheresis

Apheresis Market by End Use [Shipment Analysis by Value from 2018 to 2030]:

  • Blood Centers
  • Hospitals
  • Others

Apheresis Market by Region [Shipment Analysis by Value from 2018 to 2030]:

  • North America
  • Europe
  • Asia Pacific
  • The Rest of the World

List of Apheresis Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies apheresis companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the apheresis companies profiled in this report include-

  • Kawasumi Laboratories
  • Nikkiso
  • Haemonetics Corporation
  • Asahi Kasei Medical
  • Cerus Corporation
  • Kaneka Corporation
  • Charles River Laboratories International
  • B. Braun Melsungen
  • Fresenius Kabi
  • Terumo BCT

Apheresis Market Insights

Lucintel forecasts that centrifugation will remain the largest segment over the forecast period due to its widespread adoption in the preparation of blood components, including fresh frozen plasma and packed red blood cells.

Within this market, blood center will remain larger segment over the forecast period.

North America will remain the largest region over the forecast period due to rising adoption of cutting-edge apheresis systems and growth in the incidence of blood-related illnesses among population in the region.

Features of the Global Apheresis Market

Market Size Estimates: Apheresis market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: Apheresis market size by various segments, such as by product type, method, procedure, end use, and region in terms of value ($B).

Regional Analysis: Apheresis market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different product types, methods, procedures, end uses, and regions for the apheresis market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the apheresis market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q1. What is the apheresis market size?

Answer: The global apheresis market is expected to reach an estimated $2.3 billion by 2030.

Q2. What is the growth forecast for apheresis market?

Answer: The global apheresis market is expected to grow with a CAGR of 7.5% from 2024 to 2030.

Q3. What are the major drivers influencing the growth of the apheresis market?

Answer: The major drivers for this market are rising prevalence of chronic renal diseases, increasing government campaigns encouraging blood donation, and expanding demand for blood components.

Q4. What are the major segments for apheresis market?

Answer: The future of the apheresis market looks promising with opportunities in the blood center and hospital markets.

Q5. Who are the key apheresis market companies?

Answer: Some of the key apheresis companies are as follows:

  • Kawasumi Laboratories
  • Nikkiso
  • Haemonetics Corporation
  • Asahi Kasei Medical
  • Cerus Corporation
  • Kaneka Corporation
  • Charles River Laboratories International
  • B. Braun Melsungen
  • Fresenius Kabi
  • Terumo BCT

Q6. Which apheresis market segment will be the largest in future?

Answer: Lucintel forecasts that centrifugation will remain the largest segment over the forecast period due to its widespread adoption in the preparation of blood components, including fresh frozen plasma and packed red blood cells.

Q7. In apheresis market, which region is expected to be the largest in next 5 years?

Answer: North America will remain the largest region over the forecast period due to rising adoption of cutting-edge apheresis systems and growth in the incidence of blood-related illnesses among population in the region.

Q.8 Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

  • Q.1. What are some of the most promising, high-growth opportunities for the apheresis market by product type (disposable and reagents, software, and devices), method (centrifugation, membrane separation, and selective adsorption), procedure (donor/automated apheresis and therapeutic apheresis), end use (blood centers, hospitals, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
  • Q.2. Which segments will grow at a faster pace and why?
  • Q.3. Which region will grow at a faster pace and why?
  • Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
  • Q.5. What are the business risks and competitive threats in this market?
  • Q.6. What are the emerging trends in this market and the reasons behind them?
  • Q.7. What are some of the changing demands of customers in the market?
  • Q.8. What are the new developments in the market? Which companies are leading these developments?
  • Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
  • Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
  • Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Apheresis Market : Market Dynamics

  • 2.1: Introduction, Background, and Classifications
  • 2.2: Supply Chain
  • 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030

  • 3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
  • 3.2. Global Apheresis Market Trends (2018-2023) and Forecast (2024-2030)
  • 3.3: Global Apheresis Market by Product Type
    • 3.3.1: Disposable and Reagents
    • 3.3.2: Software
    • 3.3.3: Devices
  • 3.4: Global Apheresis Market by Method
    • 3.4.1: Centrifugation
    • 3.4.2: Membrane Separation
    • 3.4.3: Selective Adsorption
  • 3.5: Global Apheresis Market by Procedure
    • 3.5.1: Donor/Automated Apheresis
    • 3.5.2: Therapeutic Apheresis
  • 3.6: Global Apheresis Market by End Use
    • 3.6.1: Blood Centers
    • 3.6.2: Hospitals
    • 3.6.3: Others

4. Market Trends and Forecast Analysis by Region from 2018 to 2030

  • 4.1: Global Apheresis Market by Region
  • 4.2: North American Apheresis Market
    • 4.2.1: North American Apheresis Market by Method: Centrifugation, Membrane Separation, and Selective Adsorption
    • 4.2.2: North American Apheresis Market by End Use: Blood Centers, Hospitals, and Others
  • 4.3: European Apheresis Market
    • 4.3.1: European Apheresis Market by Method: Centrifugation, Membrane Separation, and Selective Adsorption
    • 4.3.2: European Apheresis Market by End Use: Blood Centers, Hospitals, and Others
  • 4.4: APAC Apheresis Market
    • 4.4.1: APAC Apheresis Market by Method: Centrifugation, Membrane Separation, and Selective Adsorption
    • 4.4.2: APAC Apheresis Market by End Use: Blood Centers, Hospitals, and Others
  • 4.5: ROW Apheresis Market
    • 4.5.1: ROW Apheresis Market by Method: Centrifugation, Membrane Separation, and Selective Adsorption
    • 4.5.2: ROW Apheresis Market by End Use: Blood Centers, Hospitals, and Others

5. Competitor Analysis

  • 5.1: Product Portfolio Analysis
  • 5.2: Operational Integration
  • 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

  • 6.1: Growth Opportunity Analysis
    • 6.1.1: Growth Opportunities for the Global Apheresis Market by Product Type
    • 6.1.2: Growth Opportunities for the Global Apheresis Market by Method
    • 6.1.3: Growth Opportunities for the Global Apheresis Market by Procedure
    • 6.1.4: Growth Opportunities for the Global Apheresis Market by End Use
    • 6.1.5: Growth Opportunities for the Global Apheresis Market by Region
  • 6.2: Emerging Trends in the Global Apheresis Market
  • 6.3: Strategic Analysis
    • 6.3.1: New Product Development
    • 6.3.2: Capacity Expansion of the Global Apheresis Market
    • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Apheresis Market
    • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

  • 7.1: Kawasumi Laboratories
  • 7.2: Nikkiso
  • 7.3: Haemonetics Corporation
  • 7.4: Asahi Kasei Medical
  • 7.5: Cerus Corporation
  • 7.6: Kaneka Corporation
  • 7.7: Charles River Laboratories International
  • 7.8: B. Braun Melsungen
  • 7.9: Fresenius Kabi
  • 7.10: Terumo BCT